The Polymotion Hip Resurfacing (PHR®) IDE study has officially passed the 60% enrolment mark, bringing us another step closer to completing this pivotal trial.
Long-Term Survivorship of Hip Resurfacing in Patients under 30
A recent study published in International Orthopaedics (2025) reports the longest follow-up to date on the outcomes of hip resurfacing arthroplasty (HRA) in patients under the age of 30.
Polymotion IDE Hip Resurfacing Study Reaches 100 Surgeries
We’re proud to share that we have successfully completed the 100th surgery in our ongoing U.S. Investigational Device Exemption (IDE) study of the Polymotion® Hip Resurfacing System.
JointMedica announces launch of IDE Study for Polymotion Hip Resurfacing System
The IDE study aims to evaluate the safety and clinical effectiveness of the PHR® System to address the challenges faced by younger, more active patients.
JointMedica Announces First Hip Resurfacing Procedures in New Zealand with Polymotion Hip Implant
Dr. Sharat Kusuma, representing JointMedica, journeyed to New Zealand to oversee the first in-patient surgeries featuring the innovative Polymotion® Hip Resurfacing
Hip Resurfacing is recognized as a key milestone in healthcare and technology advancements in the Midlands
The NHS marked 75 years of service. In honour of this, ITVX shared a newsreel featuring key milestones in healthcare and technology advances from the Midlands